Brandon Schwartz, MD
Pain Medicine · Delray Beach, FLNPI 1093160442
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Saluda Medical Americas, Inc. accounts for 65.7% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2024 at $17,107 and has fallen 91.2% since, to $1,508 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $125.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$23K
- Medtronic$3K
- Abbott$2K
- Spinal Simplicity, LLC$2K
- Nalu Medical, Inc.$1K
- Relievant Medsystems, Inc.$1K
- plus $3K from 24 others
Across 8 payments — averaging $987.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$8K
What the payments were for
- Consulting fees$20,54058%
- Travel & lodging$2,2766%
- Food & beverage$12,89836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 39 | $23,475 |
| Medtronic | 42 | $2,966 |
| Abbott | 53 | $2,379 |
| Spinal Simplicity, LLC | 33 | $1,630 |
| Nalu Medical, Inc. | 28 | $1,430 |
| Relievant Medsystems, Inc. | 14 | $1,327 |
| Boston Scientific | 17 | $593 |
| Acelrx Pharmaceuticals, Inc. | 3 | $353 |
| Vertos Medical, Inc. | 6 | $251 |
| MML US, Inc. | 5 | $226 |
| Foundation Fusion Solutions, LLC | 3 | $135 |
| Johnson & Johnson | 6 | $134 |
| Forte Bio-pharma LLC | 3 | $98 |
| Biotronik NRO, Inc. | 4 | $90 |
| Valinor Pharma, LLC | 3 | $70 |
| SPR Therapeutics, Inc | 4 | $63 |
| Globus Medical | 2 | $60 |
| Si-bone, Inc. | 2 | $57 |
| Abiomed | 2 | $55 |
| Nevro Corp. | 3 | $49 |
| Camber Spine Technologies LLC | 2 | $43 |
| Bioventus LLC | 1 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Zavation Medical Products, LLC | 1 | $37 |
| Amgen | 2 | $33 |
| Vertex | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $15 |
| Interventional Pain Technologies Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$14,516
- Evoke SCS$7,985
- Intracept$3,054
- HA MINUTEMAN G3-R$967
- ETERNA$886
- Nalu Neurostimulation System$781
- INTELLIS ADAPTIVESTIM$526
- PROCLAIM$428
- DSUVIA$353
- INTELLIS$343
- EKOSONIC$125
- ReActiv8$106
- KYPHON EXPRESS II KYPHOPAK TRAY$102
How this compares
$35,714 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 48 | $29,857 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 650 | $20,792 |
| MovantikNaloxegol Oxalate | 48 | $19,584 |
| Nucynta ErTapentadol Hcl | 13 | $15,348 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 452 | $9,136 |
| Oxycodone Hcl | 297 | $5,727 |
| OxycontinOxycodone Hcl | 11 | $5,393 |
| Fentanyl | 24 | $4,272 |
| Tizanidine Hcl | 281 | $1,928 |
| Morphine Sulfate ErMorphine Sulfate | 61 | $1,786 |
| Pregabalin | 92 | $1,722 |
| Tramadol Hcl | 179 | $1,718 |
| Lidocaine | 29 | $1,688 |
| Cyclobenzaprine Hcl | 121 | $738 |
| Gabapentin | 79 | $671 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $17 | $45,20661 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Delray Beach
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.